AWS Taps Ginkgo Bioworks, Twist Bioscience for New "Amazon Bio Discovery" Platform

AWS Taps Ginkgo Bioworks (NYSE: DNA), Twist Bioscience (NASDAQ: TWST) for New "Amazon Bio Discovery" Platform

• AWS has launched Amazon Bio Discovery, a new application that integrates 40+ AI biological foundation models with a physical lab network to slash antibody design time from years to weeks.
• Ginkgo Bioworks (DNA) and Twist Bioscience (TWST) are featured as inaugural integrated lab partners, allowing researchers to transition from AI-generated designs to physical synthesis and testing with a few clicks

You May Also Be Interested In

• Tesla Crash Into Texas Home Now Under Federal Safety Probe - WSJ
• Trump: everybody is fully aware that Iran will agree to have major weapons inspections in order to ensure "nuclear honesty" long into future
• Lockheed, RTX, Boeing, L3Harris expected to meet with Trump - WSJ